Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

Recruiting N/A Interventional Study
Bipolar Disorder Bipolar Disorder Type 1
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
100 (estimated)
Sponsor
Stony Brook University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to test how specific components of diet affect brain function and behavior for individuals with bipolar. The main question it aims to answer is how glucose and ketones each affect the brain's response to risk and reward. Participants will be asked to provide blood (to assess baseline measures of how the body uses energy), and then to receive two MRI scan sessions…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion/Exclusion Criteria: * Bipolar disorder diagnosis: Patients must have a Diagnostic Statistical Manual (DSM)-V diagnosis of bipolar disorder on the Structured Clinical Interview for DSM (SCID) * Bipolar disorder symptoms: Patients must be stable and euthymic at time of consent and testing, …
Contacts

Stephen Burke, BS

914-325-0868

stephen.j.burke@stonybrook.edu

CONTACT

Sadia Jumana, BS

339-241-2515

sadiaanjum.jumana@stonybrook.edu

CONTACT